Michael a rejoint Nanosonics en qualité de PDG et de président en octobre 2013. Il a été administrateur non exécutif du conseil d’administration de juillet 2012 à octobre 2013. Michael a plus de 26 ans d’expérience commerciale internationale sur le marché de la santé et a occupé des rôles au niveau régional et mondial dans les industries des dispositifs médicaux et pharmaceutiques. Avant de rejoindre Nanosonics, il était vice-président senior du marketing mondial pour la grande entreprise de matériel médical Cochlear Ltd, un poste qu’il a occupé pendant plus de 10 ans.

Rod joined Nanosonics in April 2019. He is a seasoned international executive with over 25 years of experience, having held critical roles in companies such as Cochlear and GM Holden. During his 13-year tenure at Cochlear, Rod held roles such as Global Head of Manufacturing and Chair of the Operational Excellence Strategy Group. At GM Holden, Rod held senior management roles across operations and global customer liaison. Rod is member of the NSW Innovation and Productivity Council, Fellow of the Higher Education Academy UK and award-winning academic with continuing Adjunct Faculty appointments for over 15 years with Macquarie Business School (formerly MGSM), AGSM@UNSW and The University of Sydney Business School.

Matt joined Nanosonics in August 2017. He was appointed to the Executive Team in October 2021, and as Company Secretary in May 2023. Matt is responsible for all legal and corporate governance matters across the Nanosonics Group. Matt is also the executive sponsor for Sustainability activities. Prior to joining Nanosonics, Matt held a variety of senior legal roles in Australia and abroad with a focus on technology and healthcare. Immediately prior to joining Nanosonics, Matt served as General Counsel for an international software business based in London. Matt is a member of the Australian Institute of Company Directors, and the Governance Institute of Australia.

Matthew joined Nanosonics in April 2022. He has over 20 years of experience in strategic marketing and product management in medical device, high technology and consulting fields across the full product development cycle. Prior to Nanosonics, Matthew held a range of strategic executive roles including Global Director of Portfolio Strategy & Planning at Cochlear, R&D management at ResMed and Founder-CEO of an enterprise SaaS software startup.

Jodi Sampson joined Nanosonics in April 2020 as the first Chief People & Culture Officer. In this role, she is responsible for developing and leading people strategies to support the transformation and growth of the business. Jodi has extensive executive experience in both ASX listed and global companies across a diverse range of industries. She has successfully developed people programs that strengthen leadership capability, improve employee engagement, and promote a diverse and inclusive culture. Before joining Nanosonics, Jodi held significant leadership roles, including Human Resources Director at Samsung and Head of Human Resources, APAC at Orange Business Services. In these roles, she was responsible for leading international human resources functions and building a culturally diverse global team.

Sunny joined Nanosonics as CIO in November 2022. He has more than 25 years of experience in Information Technology in diverse sectors such as medical device, telco and insurance, with a specific focus on Digital Transformation and Data Engineering platforms. Prior to Nanosonics, Sunny held senior management roles with Resmed, including Head of Finance Systems and Senior Director of Product Innovation.

Jason joined Nanosonics as CFO effective October 2023. Jason has more than 25 years of international experience across healthcare, construction, and financial services industries. Before joining Nanosonics he held senior finance roles with General Electric (GE) for 15 years, notably CFO for GE Healthcare Australia & New Zealand. More recently, he held several CFO roles with the Hilti group for over 6 years in Dubai and Singapore. Jason is a member of the Institute of Chartered Accountants Australia and New Zealand and attained executive education in Strategic Financial Analysis from Harvard Business School, USA.

Jon joined Nanosonics in 2012 leading the Clinical Affairs function. He has held various roles through his tenure at Nanosonics and joined the Executive Team as Chief Medical Affairs and Scientific Officer in March 2024. Jon is responsible for medical strategy, including clinical research, healthcare professional engagement, scientific communications, medical education and life sciences R&D. Prior to joining Nanosonics, Jon worked as a consultant to early-stage life sciences companies and has worked within the medical research space for over 15 years. He has served as a committee member on various standards development committees and has authored numerous scientific publications and regularly presents at international conferences.

Ken Shaw is the President of the Americas at Nanosonics Ltd., a role he has held since 2017. He leads operations across the Americas, driving the adoption of innovative infection prevention solutions like the trophon® technology for ultrasound probes. Before Nanosonics, Ken was the President of U.S. & LATAM at Amoena and held executive positions at Essity, Medicom Inc, Energizer, and Pfizer. He has a BS in Finance and an healthcare industry veteran of 25+ years.

Ronan joined Nanosonics in September 2019 and is responsible for Nanosonics’ continued expansion across Europe and the Middle East. He has more than 20 years’ experience in infection prevention through senior sales, management and business development roles with Advanced Sterilization Products and Wassenburg Medical, a global leader in endoscope reprocessing. Most recently, Ronan was the Vice President of Global Sales and a Board member at Wassenburg Medical, where he had also served as Managing Director for Ireland and Director of Business Development for EMEA.

Katsumi a rejoint Nanosonics en avril 2016 en tant que directeur national par intérim pour le Japon, et a joué un rôle important dans l’établissement et la croissance de l’activité japonaise pendant cette période. Nanosonics Japan K.K. a été créée en janvier 2019 et Katsumi a été nommé président de Nanosonics Japan K.K en septembre 2019. Katsumi possède plus de 25 ans d’expérience dans le développement et la gestion d’entreprises et d’investissements entre l’Australie et le Japon dans le secteur des sciences de la vie. Il a été membre du Conseil d’administration et a occupé des postes de direction dans de grandes entreprises internationales en Australie et au Japon.

Gareth a rejoint Nanosonics en février 2020 pour soutenir les activités existantes en Europe, au Moyen-Orient et en Afrique. Gareth apporte avec lui une grande expérience spécialisée dans le domaine de la décontamination des dispositifs médicaux invasifs réutilisables. Gareth a commencé sa carrière chez Wassenburg Medical Ireland, experts en solutions de retraitement des endoscopes et de prévention des infections, avant de rejoindre Cantel Medical Canada. Tout en soutenant leur expansion en Amérique du Nord, il a travaillé sur les produits de prévention des infections et des procédures utilisées pour l’endoscopie et les produits stériles pour les services centraux de stérilisation.

Ms. Klatt joined the Nanosonics team in October 2021. She has more than 20 years of national and international commercial experience in the healthcare market, having held local, regional and global roles in medical device industry. Before joining Nanosonics, she was working in several leadership and board roles in sales and marketing for companies like Medtronic, Hill-Rom, Baxter and Spacelabs. In addition, Ms. Klatt has been developing prospective executives in the context of training and coaching for many years. For her second degree in Marketing she was honored with the “German Study Award 2010”.